Diaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study
This study has been completed.
Sponsor:
Yonsei University
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT01054378
First received: January 21, 2010
Last updated: December 6, 2010
Last verified: December 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The temporary diaphrgmatic dysfunction will occur after stellate ganglion block(SGB) and will be easily detected by M-mode ultrasonography
| Condition | Intervention | Phase |
|---|---|---|
|
Head Pain Neck Pain Shoulder Pain Arm Pain Neural Sensory Hearing Loss |
Procedure: M-mode ultrasonography |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Yonsei University:
Primary Outcome Measures:
- The amplitude of diaphragm movement before and after SGB during quiet breathing, deep breathing and voluntary sniff, inspiratory time and expiratory time, oxygen saturation [ Time Frame: The ultrasonographic evaluation will take place just before and 30 minutes after stellate ganglion block. ] [ Designated as safety issue: No ]
| Enrollment: | 43 |
| Study Start Date: | January 2010 |
| Study Completion Date: | April 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Procedure: M-mode ultrasonography
Evaluation of diaphragmatic movement using M-mode ultrasonography before and after stellate ganglion block with 1% lidocaine
Eligibility| Ages Eligible for Study: | 20 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- ASA class I-II patients who have head and neck pain or shoulder pain or sudden sensory neural hearing loss
Exclusion Criteria:
- coagulopathy, pulmonary disease, neuropathy
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01054378
Locations
| Korea, Republic of | |
| Severance Hospital, Yonsei University College of Medicine | |
| Seoul, Korea, Republic of | |
Sponsors and Collaborators
Yonsei University
Investigators
| Principal Investigator: | Duck Mi Yoon | Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea |
More Information
No publications provided
| Responsible Party: | Duck Mi Yoon/Professor of Anesthesiology and Pain Medicine,, Yonsei University College of Medicine, Seoul, South Korea, |
| ClinicalTrials.gov Identifier: | NCT01054378 History of Changes |
| Other Study ID Numbers: | 4-2009-0614 |
| Study First Received: | January 21, 2010 |
| Last Updated: | December 6, 2010 |
| Health Authority: | Korea: Food and Drug Administration |
Additional relevant MeSH terms:
|
Neck Pain Hearing Loss Deafness Headache Hearing Loss, Sensorineural Shoulder Pain Pain Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases Sensation Disorders Arthralgia Joint Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013